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Summary The files of the Childhood Cancer Research Group and of the Oxford Survey of Childhood
Cancers were scrutinized for all the ovarian neoplasms registered in England, Scotland and Wales in children
under age 15 years throughout the period 1962-78.
Among 172 cases confirmed as malignant ovarian tumours, 145 (84%) were tumours of germ cell origin (54
dysgerminomas, 36 malignant teratomas, 26 endodermal sinus tumours, 4 embryonal carcinomas, 2 pure
choriocarcinomas, 20 mixed germ cell neoplasms, 3 gonadoblastomas), 13 (8%) were epithelial carcinomas (3
serous or undifferentiated, 10 mucinous), 9 (5%) were sex-cord stromal tumours (3 granulosa cell, 3 Sertoli-
Leydig, 3 unclassified) and 5 (3%) were other miscellaneous tumour types.
Less than 10% of the neoplasms occurred at age <5 years, -20% from 5-9, and >70% from 10-14 years.
Germ cell neoplasms of greater malignancy (immature teratomas, endodermal sinus tumours) occurred in a
significantly higher proportion at younger age ( < 10 years) than dysgerminomas (P=0.01).
The overall incidence (- 1.7 cases per 106 per annum) did not show any noticeable trend over the 17-year
period considered.
The clustering of two confined cases and, possibly, a third case, of germ cell neoplasms in three
generations of the same family pointed to a genetic component in the aetiology of some of these neoplasms.
A large number of sex related and mental or neurological abnormalities was also reported in case children.
The 10-year survival rates, determined by the life-table method were: epithelial carcinomas 73%, sex-cord
stromal tumours 44%, dysgerminomas 73%, malignant teratomas 33%, endodermal sinus tumours 39%,
embryonal carcinomas 25%, other germ cell neoplasms 30% and gonadoblastomas 100%. Apart from cell-
type, factors associated with prognosis were clinical stage (in all types), size and degree of histological
differentiation (in malignant teratomas, but only when stage was not allowed for). The adoption of efficacious
polychemotherapy regimens completely changed the prognosis of germ cell tumours other than
dysgerminomas (from 29% to >85% disease-free survivors in the present series).
Ovarian tumours are extremely rare in infants and
children, representing a small proportion of all
ovarian neoplasms (-0.2-0.3% of such tumours
occur in girls under 15 years, OPCS, 1980-82). The
childhood tumours do, however, include many
distinct pathological and clinical entities, with
differing epidemiology, therapeutic approach and
prognosis.
The great variety of types and the structural
complexity of the pathological classification have
hindered efforts at analytical studies on appropriate
numbers: although a considerable number ofpapers
dealing with this subject have been published over
the last few years, the great majority are single-case
reports. The few series reporting greater numbers of
patients are mostly based on hospital case lists
(Breen & Maxson, 1977), from which only
unreliable estimates of the relative frequency can be
derived, and often include both benign and
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malignant tumours. A few other reports are based
on mortality data (Li et al., 1973) or pathological
series (Norris & Jensen, 1972). The analytical series
based on tumour registries are even rarer: one is
based on 81 cases (including 54 malignant) in
Finnish and Swedish children (Lindfors, 1971), and
one on 40 cases seen in the Manchester region
between 1940 and 1977 (Lucraft et al., 1980).
The recording of all the registration of malignant
tumours occurring in Britain in children below age
15 at the Childhood Cancer Research Group
(CCRG) made feasible a study on a large
population-based series. The present paper is based
on a review ofthe clinical and pathological material
of all the cases of malignant ovarian tumours
registered from 1962 to 1978.
In addition to analyzing the histopathological
distribution, we briefly consider a few risk and
associated factors, and summarize the outline of
clinical presentation, therapeutic approach and
long-term survival for each of the various cell types.
Patients and methods
The records of the Childhood Cancer Research
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Group (CCRG) include registrations for all
children aged under 15 who were notified to the
National Cancer Registration Scheme with a
diagnosis of malignant ovarian tumour during the
period 1962-78. A total of 183 patients met this
criterion. Although cancer registration is thought to
be incomplete, an estimate of the completeness of
ascertainment has been given for other childhood
neoplasms, and is in general assumed to range from
85-95%, with a trend towards more complete
ascertainment over recent years (Draper et al.,
1982).
A standard form with the characteristics of the
patients and their tumours, outlines of diagnostic
and therapeutic procedures and follow-up was
available for each patient at the CCRG
(registrations from 1971 onwards), or at the Oxford
Survey of Childhood Cancers (OSCC) (registrations
from 1962 to 1970).
Interviews by the OSCC with the mother or the
general practitioner (GP) containing information on
family and pregnancy history were searched for all
cases registered in the period 1962-69, and for all
cases with death certificates in the period 1970-78
who had been interviewed. Such interviews were
available for 80 cases.
The date of diagnosis, the cell type and the major
tumour and patient's characteristics were routinely
checked, whenever possible, against hospital
records, and amended whenever necessary.
Staging was evaluated retrospectively and
expressed in terms of the FIGO classification.
On account of the importance of correct histo-
pathological classification in this disease, and the
necessity to update diagnoses according to changed
criteria for classification, a specific attempt was
made to collect and review all the pathological
material.
The revision of clinical notes and pathological
material resulted in exclusion of 13 cases. Review
for a companion study (La Vecchia et al., 1983a) of
the cases registered in the same period with
diagnosis of "non-ovarian female genital tract
tumour" led to the inclusion of 2 cases originally
classified as "undifferentiated sarcomas probably of
salpingeal origin", and which were found to be
ovarian endodermal sinus tumours.
The total number of cases in the present report is
therefore 172. Among them, 137 (80%) can be
considered adequately documented from the
pathological aspect (slides and original reports had
been collected) while in 23 (13%) cases only the
pathological report was available.
It is of interest to compare the original with the
revised diagnoses (Table I). In a total of 42/160
(26%) cases the diagnosis was modified: most of
the changes, however, were within the various
groups of non-dysgerminomatous germ cell
tumours and, therefore, of relatively limited clinical
and prognostic relevance.
All the pathological material was reviewed by
one of us (H.B.M.). Immunoperoxidase AFP and
hCG stainings were performed whenever indicated.
Grading for malignant teratomas was made
according to Robboy & Scully criteria (1970).
Follow-up information was obtained mainly
through the hospitals or the GPs 3-6 years (average
4) after registration, and the data were updated
accordingly. All the cases were then "flagged" at
the National Health Service Central Registry, so
that notification of subsequent neoplasms or death
was obtained directly from this source.
Tests of statistical significance for contingency
tables were based on chi-square values with
continuity correction. Tests based on the binomial
distribution are exact.
The calculation of life tables was performed by
the actuarial method. Survival curves were
compared by the usual log-rank test (Peto et al.,
1977), adjustments and tests for linear trend, when
appropriate, being made by computing the variance
of the difference between observed and expected
numbers of events.
Although follow-up information was available for
up to 20 years for some of the patients, no death
was observed after > 10 years, so only 10-year rates
are presented.
Results
Incidence, age and histotype distribution
The average overall annual incidence for all types
of neoplasms was 1.7 cases per 106 (based on the
mean annual female population under age 15,
England, Wales and Scotland, 1962-78). The
incidence rate did not show any trend over the 17-
year period considered. However, when separate
categories of neoplasm were analysed, an increase
was evident in the incidence of endodermal sinus
tumours (EST) (4 cases registered in the period
1962-69 vs 22 in the period 1970-78, P<0.001l
based on the binomial distribution). This finding
cannot be explained on the basis of altered
classification criteria, as most of the cases had been
histologically reviewed (see Methods).
The distribution of the 172 cases according to
histological type and age is shown in Table II. It is
of interest to note that: (i) Most (10/13) of the
tumours of epithelial origin were classified as
mucinous in type and of these 4 were of borderline
malignancy. (ii) Neoplasms of germ cell origin, not
surprisingly, represented the great majority
(145/172, 84%) of all childhood ovarian cancers.
Among them a considerable proportion (14%), wasMALIGNANT OVARIAN TUMOURS IN CHILDHOOD 365
Table I Comparison of original vs revised diagnosis 160a cases of malignant ovarian tumours in childhood. CCRG, Britain,
1962-78.
Original Diagnosis
Malignant EST/Embryonal Other Germ- Gonado- Epithelial Sex-Cord
Dysgerminoma Teratoma Carcinoma Cell blastoma Carcinomasb Stromal Others
Revised Diagnosis
Dysgerminoma 43 1 2 3
Malignant Teratoma 27 1 2 3
EST* Embryonal
Carcinoma 3 2 18 2 3 1
Other Germ-Cell 1 3 3 11 1 1 1
Gonadoblastoma 3
Epithelial
Carcinomas 12
Sex-cord Stromal 1 1 6
Others 2 1 1 1
aOnly cases on which some pathological documentation was obtained included (see "Methods"). The original diagnoses of
the 12 unreviewed cases were as follows:
Dysgerminoma (5)
Malignant Teratoma (3)
Embryonal Carcinoma (1)
Choriocarcinoma (1)
Granulosa Cell Tumour (1)
Undifferentiated Carcinoma (1)
Of these patients, 7 were diagnosed during 1962-69 and the remaining 5 during 1970-78.
bMost of the cases which were re-classified were simply registered as "Carcinoma, not otherwise specified".
composed of two or more cell types: 7 immature
teratomas plus EST (in 3 cases with areas of
choriocarcinoma), 7 teratomas plus dysgerminomas
(and areas of EST, in 3 cases) 2 dysgerminomas
plus choriocarcinoma, 1 with EST and 1 with
embryonal carcinoma areas. Two cases were
unclassifiable mixed germ cell neoplasms. (iii) The
cases classified as "others" consisted of 2 patients
with primary ovarian Burkitt-like lymphoma (one
plus ALL), 2 lipoid cell tumours, and a low-grade
sarcoma probably of fibroblast origin.
A total of 11 (6%) neoplasms occurred at <5
years of age, 36 (21%) from age 5-9 years and 125
(73%) from 10-14 years (Table II).
While sex-cord stromal tumours appeared more
or less uniformly distributed in the various age
groups and epithelial tumours were concentrated in
the later years, there was a considerable change in
the distribution of germ cell tumours over age.
More "invasive" neoplasms tended to occur with a
higher frequency at a younger age (< 10 years),
while "less malignant" tumours (dysgerminomas)
were proportionally more frequent in the later age
groups (X2=6.0; P =0.01; Table II).
Risk and associatedfactors
A total of 24 (14%) patients had one or more
congenital defects: these are listed according to cell
type, in Table III. Most of them were
morphological abnormalities of external or internal
genitalia.
As regards family history, a cluster of 2 (and
possibly 3) cases of ovarian germ cell neoplasms
was found in one family. The mother of a child
with a bilateral dysgerminoma had died of an
ovarian dysgerminoma plus choriocarcinoma,
diagnosed in pregnancy. This patient's grandmother
had also had an ovarian tumour, possibly a
dysgerminoma. This case had already been reported
(Jackson, 1967), but it is now possible to give a
rough estimate of the conditional probability of
finding two or more members of the same family
with an ovarian germ cell tumour. Assuming that
the probability of a woman developing a germ cell
tumour of the ovary is about 1 in 2000, and that in
three generations of the same family there are
about 5 women, one should expect to find one
further case of germ cell tumour in one out of 500
families of an affected patient, and two further
cases in one 6.7 x i0' families. It seems therefore
extremely unlikely that even this single cluster can
have occurred by chance.
As far as risk factors during pregnancy are
concerned, among interviewed cases (see Methods),
none of the considered exposures (X-rays,
hormones, sedatives or tranquillizers) or diseases
(mainly infections, such as cystitis, pyelitis, chickenI
Cq en
0
4
0 00
cq
CA
CA
Cd M, 4) K 0
00 C4 N m u
el
ON
Cd
C4
ts
rA
C14 ON
0 + Cd U
v
-4 C'4
rA
Cd ;s
A cd,r. o Cd
0.5 0 Cd 0 Cd
>1 >1 > >.b >
14 I'll
cd 00 rA 4w,
cii
Cd Cd
,Q :Z: St
ri
o 0.
U W W
366 C. LA VECCHIA et al.MALIGNANT OVARIAN TUMOURS IN CHILDHOOD 367
pox, rubella or influenza) was significantly more
common among the cases than among their
matched controls.
Stage, size, and site ofoccurrence
The distribution according to cinico-pathological
stage and histological categories is given in Table
IV. A total of 80 cases (47%) were stage I, 5 (3%)
stage II, 77 (46%) stage III and 7 (4%) stage IV.
Most of the neoplasms were of considerable
volume, 91% having a maximum diameter > 10cm.
Eighty-nine tumours (55%) occurred in the right
ovary, 62 (38%) in the left (P=0.03, exact
binomial), 11 (7%) were bilateral. The difference in
the site of occurrence was accounted for only by
the germ cell tumours (80 right, 49 left, P=0.008),
other cell types occurring in similar proportions in
the two gonads.
Therapeutic approach
The outlines of first-line therapeutic approach are
summarized in Table V. Surgery was the first
obvious treatment step: most of the cases (123,
73%) were treated by unilateral (salpingo)
oophorectomy, irrespective of the cell type.
Radiotherapy (in most of the cases external-beam
radiotherapy to the pelvis or pelvis plus abdomen
or plus paraortic nodes) was given to a total of 74
patients, and, not surprisingly, was more commonly
used in dysgerminomas. It was also employed as a
treatment for recurrence in 27 patients. At least one
chemotherapy regimen was given only to a minority
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75
50
-i~ .D
2 0L
25
ofthe patients (41/170, 24%), but the proportion of
chemotherapy-treated patients increased over more
recent years (from 8% in the period 1962-71 to
44% from 1972 onwards).
VAC regimen (vincristine, actinomycin D, cyclo-
phosphamide) was given to 12 patients with germ
cell neoplasms, whereas only two patients up to
1978 received any of other newer regimens, such as
PVB (cisplatinum, vincristine, bleomycin).
A total of 28 patients received chemotherapy for
the treatment of recurrences.
Survival
The 10-year survival curves according to individual
histological types are presented in Figure 1. Overall,
long-term survival was achieved in approximately
one in two patients.
Apart from cell type, the only other variable with
a clear prognostic significance when the whole case
series is considered was clinical stage (Figure 2). No
significant diffference was evident according to age
at diagnosis in 5-year groups, type of hospital (e.g.
teaching vs non-teaching), and in all cell types
together, size of the neoplasms.
A few specific comments can be made regarding
the different tumour types. Among epithelial
carcinomas, whose overall 10-year survival was
73%, the three deaths were among mucinous (2
cases) and undifferentiated carcinomas (1 case), all
stage III. None of the borderline mucinous adeno-
carcinomas died of disease, though one of them
was stage III at diagnosis.
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Figure1 Comparative l-yearsurvivalratesaccordingtohistologicaltype. 172casesofmalignantovariantumours
in childhood, CCRG, Britain, 1962-78.
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Figure2 Comparative l0-yearsurvival ratesaccordingtostage(FIGO). 169 casesofmalignantovariantumoursin
childhood, CCRG, Britain, 1962-78. x2 for linear trend= 63.89: P<0.001.
In malignant teratomas, prognosis was influenced
by clinical stage, degree of histological differ-
entiation and size of the neoplasm (Figure 3).
However, these three variables were obviously
strongly correlated, and, when they were
respectively adjusted with each other only the stage
remained statistically significant.
The overall 10-year survival rate among the 20
cases of mixed germ cell tumours was similar to the
one for "most malignant" germ cell neoplasms.
However, survival was significantly higher in cases
containing areas of dysgerminoma (53% achieving
long term survival) than in tumours composed only
of other cell types (EST, embryonal carcinoma,
teratoma, choriocarcinoma. 0/7 patients being alive
>3 years after original diagnosis; X% =5.29,
P =0.02).
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Figure3a Comparative 10-yearsurvival ratesaccording
to stage (FIGO). 35 cases of malignant teratomas in
childhood. CCRG, Britain, 1962-78. x2 for linear trend
=27.08, P<0.001; adjusted for grade and size = 11.52,
P<0.001.
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The major prognostic indicator among germ cell data. Moreover, the follow-up information can be
neoplasms other than dysgerminomas was the use considered practically complete.
of adequate chemotherapy regimens (VAC/PVB): As concerns descriptive epidemiology, this study
survival was 86% among 14 treated patients, but has not shown any trend in the incidence of (or
only 29% among 77 inadequately treated patients, mortality from) childhood ovarian tumours over
a statistically significant difference, at the 0.001 the 17-year period considered. This finding is in
level (X'=18.90) when clinical stage is adjusted for agreement with the OPCS mortality data (OPCS,
(Figure 4). 1975) and with similar reports on ovarian tumours
in younger children from Scandinavian countries
100 (Lindfors, 1971) and the USA (Li et al., 1973).
E " '" '"' VAC/PVB However, it is at variance with the increase in germ
75
A cell tumours (which represent 84% or our series) g5 treported by the Manchester Children's Tumour
Registry (Birch et al., 1982), and with the
D50 _ established increase in (germ cell) testicular cancer
(Davies, 1981), which however, is mainly evident in
0
25- 2 older groups. 7 Other or no On the other hand, the present data are in Cherrfotwapy agreement with the Manchester series (Birch et al.,
l I 1982) in reporting a noticeable increase in yolk-sac 0 1 2 3 4 5 6 7 8 9 10 tumours; nonetheless, we do not think it is worth
Time (y) to death or follow-up over-stressing the increase, however significant,
Figure 4 Comparative 10-year survival rates according considering the very low absolute number, and the
to the use of chemotherapy. 91 cases of non fact that, when many different sub-groups are
dysgerminomatous germ cell tumours. CCRG, Britain, considered, it is quite likely that some variations in 1962-78. x2=10.70; P=0.001; adjusted for stage= 18.90, rats ared Simply bychance.
P<0.001 ' '' rates are found simply by chance.
Subsequent pregnancy history and long-term follow-
up
Five patients (2 with dysgerminomas, one with
mucinous cystadenocarcinoma, one with
borderline mucinous cystadenocarcinoma, one with
malignant teratoma, all of which were Stage I) had
a total of 6 live births. There was no evidence of
any abnormality in the offspring.
Only one patient developed a second neoplasm.
At age 14 she had received radiotherapy to the
pelvis and abdomen for the treatment of a Stage III
dysgerminoma, and at age 27 she developed a
carcinoma of the pelvic colon (histologically
confirmed).
Discussion
The present study is based on the largest
population-based series of malignant ovarian
tumours reported to date. Although some
information was collected retrospectively, the
consistent use of the original hospital records
should have prevented the introduction of any
important discrepancy in the quality of the data
over the 17-year period. Similarly, the revision of
80% of the pathological material (based on sections
from each of the several tumour blocks), and of
93% of the pathological reports has resulted in a
satisfactory degree of reliability of the classified
Histopathologicalfindings
The histotype distribution if the present series
appears in broad agreement with previous work
(Groeber, 1963; Lindfors, 1971; Norris & Jensen,
1972; Li et al., 1973; De Palo et al., 1978; Lucraft
et al., 1980) germ cell tumours representing by far
the majority (>80%) of all childhood ovarian
cancers.
The percentage of sex-stromal tumours in our
series (5%) is lower than suggested in previous
series (Breen & Maxson, 1977). However, their
percentage seems likely to be an overestimate,
possibly because of misclassification of some germ
cell tumours (mainly dysgerminomas) as poorly-
differentiated granulosa cell tumours, or to the
inclusion of benign tumours of the fibroma-
thecoma group.
When germ cell neoplasms are considered, it is
worth noting that a careful pathological revision
shows that a considerable proportion (14%) of
them are composed of two or more cell types
(mixed germ cell tumours), a finding which has
obvious implications both for treatment and
prognosis.
Risk and associatedfactors
The present study has confirmed the association of
a high proportion (2 out of 3 cases) of gonado-
blastomas with the typical features of gonadal372 C. LA VECCHIA et al.
dysgenesis (Scully, 1977). It is also of interest to
mention that gross sex-related abnormalities were
present in 6/142 (4%) of other germ cell tumours
(Table III).
Similarly, the proportion of severe mental or
neurological abnormalities (7 affected patients in
the whole series) is higher than expected, and no
obvious explanation can be given for this
association. However, sex-related chromosomal
abnormalities are also often related both to
abnormal sexual development and to mental
handicap.
A high incidence of congenital defects, reflecting
a similar pattern, was found in the series described
by Fraumeni et al. (1973) and Birch et al. (1982).
The latter postulated a common embryological
defect which involves the lower spinal axis and
hindgut, resulting in the development of both
teratomas and pelvic anomalies.
None of the factors related to mothers'
pregnancies we were able to analyse was related to
the risk of developing an ovarian tumour in
childhood.
Therefore, the only factor which was found to be
of importance in some cases is the family history as
confirmed by the cluster of two (perhaps three)
cases of dysgerminoma in one family (another
family cluster of germ cell neoplasms in three sisters
and two other related members of the same family
was registered in 1979, and is therefore not
considered in the present report-see Mann et al.,
1982).
That a genetic component represents an
important aspect of the risk of developing germ cell
neoplasms finds support in three other sets of data:
the reported familial occurrence of benign
teratomas in women (Hecht et al., 1976); the
clustering of germ cell testicular tumours in twins
and sibs (Levey & Grabstald, 1975), and their
association with HLA DW7 and AIO (De Wolf et
al., 1979); and the animal models of germ cell
tumours (Graham, 1982).
In addition, it is of interest to comment on the
relationship between the age distribution of the
various types of germ cell neoplasms and the
"invasiveness" of the tumours themselves: "more
malignant" tumours occur at significantly lower
ages than dysgerminomas; these in turn occur
earlier than benign teratomas which are found
mainly in adult life. This finding may well provide
some support for the view that these tumours have
a common origin with, however, different growth
patterns apparently proportional to the degree of
malignancy of the neoplasm itself.
The occurrence of epithelial cancers in the later
age groups (all after menarche) may be taken as a
confirmation of their dependence on gynaecological
events, and, perhaps, their hormonal correlates (La
Vecchia et al., 1983b). An individual case worth
mentioning in this regard concerns a patient with
bilateral serous cystadenocarcinoma associated with
long-standing gross obesity. It is now believed
(Siiteri, 1978) that adipose tissue is an important
site of peripheral aromatization of adrenal
androgens to oestrogens.
No case of definite prepuberal epithelial
carcinoma has been found in this series. Only two
previous reports of such an occurrence are
described in the world literature (Hong et al., 1980;
Blom & Torkildsen, 1982).
Ten out of 13 epithelial cancers were of mucinous
type, which, interestingly enough, has been
suggested as deriving from teratomatous origin
(Fox et al., 1964; Langley et al., 1972). Among
them, 4 were of borderline malignancy, a
proportion which, even allowing for the small
absolute numbers, seems far higher than in the
adult-onset neoplasms. It may therefore be worth
looking at these forms as first stages in the same
multi-step process ofcarcinogenesis.
Therapeutic approach
As regards primary treatment, there appears to be
little debate on the surgical approach, unilateral
(salpingo)-oophorectomy being commonly accepted
as the first-line treatment in stage IA disease. A
conservative approach in early neoplasms allowed
conservation of fertility in a proportion of patients
(5 of our cases had a total of 6 normal births).
The introduction ofefficacious polychemotherapy
regimens certainly represents the most impressive
change introduced over the last decade in the
management of germ cell neoplasms. Survival in
non-dysgerminomatous germ cell neoplasms
increased from 29% in untreated patients or
patients inadequately treated with chemotherapy to
86% in adequately treated ones (Figure 4). The
efficacy of VAC, the first successfully introduced
regimen (Smith & Rutledge, 1975) is confirmed in
our series, although non-randomized and collected
from 10 different hospitals. However, it seems more
plausible to assume differences in treatment policies
between different hospitals than systematic
differences in tumour characteristics (as, for
instance, adjustment for stage even increased the
value of statistical significance). This may well
confirm its efficacy even outside very strict "trial"
conditions and, simultaneously, underlines the
necessity that every patient with one of these
tumour types should be given the opportunity to
receive adequate treatment (considering only the
period 1972-1978, 31 patients were treated in 29
other hospitals with inadequate, or no medical
treatment: among them only 11 are alive).MALIGNANT OVARIAN TUMOURS IN CHILDHOOD 373
Survival
As far as survival is concerned, apart from the clear
relationship with cell type, and the reliability of
clinical stage as a prognostic indicator, in the series
as a whole no other factor appears relevant.
However, some specific observations can be made
regarding the different tumour types.
Among the 13 epithelial cancers, the overall 73%
survival rate appears higher than the 30-35%
commonly reported in adult-onset cancers, and in
other small series of epithelial neoplasms in children
(Breen & Maxson, 1977). This is probably
attributable both to the clinical stage (9/13 patients
were Stage I), and to the high proportion of
mucinous adenocarcinoma of borderline
malignancy in the cases in our series.
On the other hand, the prognosis of our limited
series of granulosa cell tumours (all 3 cases died of
disease after 2-11 months) appears far inferior than
that reported for this cell type (Roth et al., 1979;
Young & Scully, 1982). The absolute number of
cases reported, however is extremely low, and
therefore studies on larger numbers of cases are
necessary before knowledge of behaviour of these
neoplasms is definitive.
While, not surprisingly, dysgerminomas had a
fairly good prognosis (10-year survival, 73%), the
broad group of germ cell tumours other
than dysgerminoma, however heterogeneous
morphologically, seems to exhibit fairly similar
overall clinical behaviour. This appears worth
stressing in the light of the similarities in general
therapeutic approach and chemosensitivity.
It is moreover of interest to make a few
distinctions not only between, but also within
various cell-types. Among the 36 cases of malignant
teratoma, for instance, not only clinical stage, but
also tumour size and degree of histological
differentiation seemed to have a noteworthy impact
on prognosis. This confirms a similar observation
originally made by Norris et al. (1976). However,
when these three variables were adjusted to each
other, only the effect of clinical stage on prognosis
remained statistically significant.
The prognosis of mixed germ cell tumours (which
represent a considerable proportion in the present
series) appears extremely poor, particularly when
dysgerminomatous areas are not present, and once
again underlines the need for extremely careful
histopathological analysis and classification as a
prerequisite of any rational therapeutic approach.
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